Original Research

Published on 10 Apr 2024

A study demonstrating users’ preference for the adapted-REQUITE patient-reported outcome questionnaire over PRO-CTCAE® in patients with lung cancer

in Thoracic Oncology

Thomas Jordan
Thitikorn Nuamek
Isabella Fornacon-Wood
Raffaele Califano
Joanna Coote
Margaret Harris
Hitesh Mistry
Paul Taylor
David Woolf
Corinne Faivre-Finn

Frontiers in Oncology

doi 10.3389/fonc.2024.1328871

1,242 views
1 citation

Brief Research Report

Published on 10 Apr 2024

Proteasome inhibition paradoxically degrades gain-of-function mutant p53 R273H in NSCLC and could have therapeutic implications

in Thoracic Oncology

Eziafa I. Oduah
Susan T. Sharfstein
Nagashree Seetharamu
Steven R. Grossman
Larisa Litovchick

Frontiers in Oncology

doi 10.3389/fonc.2024.1363543

999 views

Case Report

Published on 09 Apr 2024

A case report of typical well-differentiated papillary mesothelial tumor diagnosed by internal thoracoscopy and literature review

in Thoracic Oncology

Jian Guo
XiaoHui Lv
Wei Zhang
Fang Dong
Lei Li
Juan Liu
Bing Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1359985

660 views

Original Research

Published on 08 Apr 2024

A study of high dose furmonertinib in EGFR exon 20 insertion mutation-positive advanced non-small cell lung cancer

in Thoracic Oncology

Song Hu
Hao Ming
Qian He
Ming Ding
Hao Ding
Chong Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1314301

1,467 views

Correction

Published on 08 Apr 2024

Corrigendum: Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis

in Thoracic Oncology

Reem Altaf
Umair Ilyas
Anmei Ma
Meiqi Shi

Frontiers in Oncology

doi 10.3389/fonc.2024.1377858

453 views

Original Research

Published on 08 Apr 2024

Anlotinib in Chinese patients aged ≥70 years with advanced non-squamous non-small cell lung cancer without prior chemotherapy: a multicenter, single-arm pilot trial

in Thoracic Oncology

Da Zhao
Zhengguo Li
Xinli Hou
Lei Yang
Zeng Li
Li Yan
Hongling Li
Hua Liu
Xiaoping Liu
Feixue Song

Frontiers in Oncology

doi 10.3389/fonc.2024.1335009

955 views

Case Report

Published on 04 Apr 2024

Case report: Envafolimab combined with Endostar in the treatment of advanced non-small cell lung cancer with malignant pleural effusion

in Thoracic Oncology

Changhong Dong
Chenxi Hu
Yanting Jiang
Kaiyuan Hui
Xiaodong Jiang

Frontiers in Oncology

doi 10.3389/fonc.2024.1368059

925 views

Original Research

Published on 02 Apr 2024

Clinical significance of miR-9-5p in NSCLC and its relationship with smoking

in Thoracic Oncology

Tian-Xiang Zhang
Xin-Chun Duan
Yong Cui
Ye Zhang
Meng Gu
Zi-Yu Wang
Wei-Ying Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1376502

1,007 views

Case Report

Published on 02 Apr 2024

Uniportal video-assisted thoracoscopic segmentectomy for fetal adenocarcinoma lung cancer with severe pulmonary emphysema: a case report

in Thoracic Oncology

Yun-Sheng Wu
Yu-Ting Chen
Jen-Hao Chuang
Hsien-Chi Liao

Frontiers in Oncology

doi 10.3389/fonc.2024.1281211

741 views

Case Report

Published on 27 Mar 2024

Outcomes of non-small cell lung cancer patients with non-V600E BRAF mutations: a series of case reports and literature review

in Thoracic Oncology

Raluca Lazar
Cathie Fischbach
Roland Schott
Laura Somme

Frontiers in Oncology

doi 10.3389/fonc.2024.1307882

1,798 views

Original Research

Published on 27 Mar 2024

A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL)

in Thoracic Oncology

Alessandro Cafaro
Flavia Foca
Oriana Nanni
Marco Chiumente
Marina Coppola
Paolo Baldo
Sabrina Orzetti
Fiorenza Enrico
Vito Ladisa
Rosa Lerose

Frontiers in Oncology

doi 10.3389/fonc.2024.1351995

2,413 views
1 citation

Review

Published on 27 Mar 2024

A review of perioperative treatment strategies with immunotherapy and tyrosine kinase inhibitors in resectable and stage IIIA-N2 non-small cell lung cancer

in Thoracic Oncology

Madeleine B. Hopson
Sawsan Rashdan

Frontiers in Oncology

doi 10.3389/fonc.2024.1373388

2,204 views

Case Report

Published on 25 Mar 2024

Case report: Molecular profiling facilitates the diagnosis of a challenging case of lung cancer with choriocarcinoma features

in Thoracic Oncology

Hui Li
Xin Hu
Matthew S. Ning
Gregory N. Fuller
John M. Stewart
Jared C. Gilliam
Jia Wu
Xiuning Le
Ara A. Vaporciyan
J. Jack Lee

Frontiers in Oncology

doi 10.3389/fonc.2024.1324057

1,618 views

Case Report

Published on 25 Mar 2024

Case report: EGFR fusion mutation combined with EGFR amplification responds to EGFR-TKI therapy

in Thoracic Oncology

Zhulin Wang
Chunyao Huang
Wenbo Fan
Shaowu Sun
Kaiyuan Li
Xu Liu
Jiangtao Pu
Guoqing Zhang
Xiangnan Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1347282

1,247 views

Editorial

Published on 20 Mar 2024

Editorial: Case reports in thoracic oncology: 2022

in Thoracic Oncology

Yaron Perry

Frontiers in Oncology

doi 10.3389/fonc.2024.1369799

737 views

Brief Research Report

Published on 20 Mar 2024

Understanding the perceived benefits, barriers, and cues to action for lung cancer screening among Latinos: A qualitative study

in Thoracic Oncology

Edgar I. Alaniz-Cantú
Kalese Goodwin
London Smith
Eliany Acosta
Arlette Chávez-Iñiguez
Mary Jo Evans
Marcela Gaitán
Fang Lei
Reza Yousefi-Nooraie
Kevin A. Fiscella

Frontiers in Oncology

doi 10.3389/fonc.2024.1365739

1,414 views

Navigation group

Articles

A study demonstrating users’ preference for the adapted-REQUITE patient-reported outcome questionnaire over PRO-CTCAE® in patients with lung cancer

Proteasome inhibition paradoxically degrades gain-of-function mutant p53 R273H in NSCLC and could have therapeutic implications

A case report of typical well-differentiated papillary mesothelial tumor diagnosed by internal thoracoscopy and literature review

A study of high dose furmonertinib in EGFR exon 20 insertion mutation-positive advanced non-small cell lung cancer

Corrigendum: Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis

Anlotinib in Chinese patients aged ≥70 years with advanced non-squamous non-small cell lung cancer without prior chemotherapy: a multicenter, single-arm pilot trial

Case report: Envafolimab combined with Endostar in the treatment of advanced non-small cell lung cancer with malignant pleural effusion

Clinical significance of miR-9-5p in NSCLC and its relationship with smoking

Uniportal video-assisted thoracoscopic segmentectomy for fetal adenocarcinoma lung cancer with severe pulmonary emphysema: a case report

Outcomes of non-small cell lung cancer patients with non-V600E BRAF mutations: a series of case reports and literature review

A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL)

A review of perioperative treatment strategies with immunotherapy and tyrosine kinase inhibitors in resectable and stage IIIA-N2 non-small cell lung cancer

Case report: Molecular profiling facilitates the diagnosis of a challenging case of lung cancer with choriocarcinoma features

Case report: EGFR fusion mutation combined with EGFR amplification responds to EGFR-TKI therapy

Editorial: Case reports in thoracic oncology: 2022

Understanding the perceived benefits, barriers, and cues to action for lung cancer screening among Latinos: A qualitative study